AR054215A1 - Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit - Google Patents
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kitInfo
- Publication number
- AR054215A1 AR054215A1 AR20060100208A ARP060100208A AR054215A1 AR 054215 A1 AR054215 A1 AR 054215A1 AR 20060100208 A AR20060100208 A AR 20060100208A AR P060100208 A ARP060100208 A AR P060100208A AR 054215 A1 AR054215 A1 AR 054215A1
- Authority
- AR
- Argentina
- Prior art keywords
- taxane
- composition
- solid composition
- acetic acid
- solution
- Prior art date
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 title abstract 18
- 229940123237 Taxane Drugs 0.000 title abstract 11
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 title abstract 11
- 239000008247 solid mixture Substances 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 5
- 230000003381 solubilizing effect Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000000243 solution Substances 0.000 abstract 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 abstract 2
- 238000004108 freeze drying Methods 0.000 abstract 2
- 239000002736 nonionic surfactant Substances 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 239000003978 infusion fluid Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Epoxy Compounds (AREA)
Abstract
Una formulacion farmacéutica inyectable de un taxano, apta para ser utilizada en soluciones de infusion parenteral para mamíferos, preferentemente para humanos, que comprende una composicion solida de dicho taxano, liofilizada desde una solucion de ácido acético y una composicion solubilizante de dicha composicion solida. Donde la composicion solubilizante comprende una sal equimolar de ácido biliar, en particular desoxicolico, y una etanolamina, preferentemente trietanolamina, un alcohol, y agua o dicha composicion solubilizante comprende tensoactivo no ionico, alcohol y opcionalmente agua y ácido acético. Y la composicion solida de dicho taxano comprende un liofilizado a partir de una solucion de dicho taxano en ácido acético, la que pede contener agua y un excipiente de liofilizacion. Un procedimiento para la preparacion de dicha composicion solida de un taxano, que comprende los siguientes pasos: disolver dicho taxano en ácido acético, agregar agua en una concentracion de 0 a 80% p/p de la solucion total; agregar un excipiente de liofilizacion en una concentracion de entre 0 y 15% p/p de la solucion total; liofilizar; y secar opcionalmente. Un conjunto de elementos (kit) que comprende: un recipiente que contiene una solucion de dextrosa al 5% o una solucion salina normal, alcohol en una concentracion de entre 0,5 y 5% y un tensoactivo no ionico en una concentracion entre 0 y 3%; un segundo recipiente que contiene una composicion solida de taxano liofilizado desde una solucion de ácido acético, un tercer recipiente que contiene una solucion solubilizante de dicha composicion solida de taxano, y una jeringa.
Priority Applications (28)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AR20060100208A AR054215A1 (es) | 2006-01-20 | 2006-01-20 | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
| PCT/ES2007/070012 WO2007082978A1 (es) | 2006-01-20 | 2007-01-18 | Una formulación farmacéutica de taxano, una composición sólida de taxano, un procedimiento para la preparación de dicha composición sólida de taxano, una composición solubilizante de dicha composición sólida de taxano, y un conjunto de elementos (kit) par |
| BRPI0706931-6A BRPI0706931A2 (pt) | 2006-01-20 | 2007-01-18 | uma formulação farmacêutica que compreende um taxano, uma composição sólida de taxano, um processo para preparar dita composição sólida de taxano, uma composição de solubulização de dita composição de taxano, e um kit de formulação injetável de taxano |
| JP2008550785A JP2009523770A (ja) | 2006-01-20 | 2007-01-18 | タキサン医薬製剤、固形タキサン組成物、前記固形タキサン組成物の調製方法、前記固形タキサン組成物を可溶化するための組成物および注射可能なタキサン製剤のための構成要素のセット（キット） |
| EP07712569A EP1994925A4 (en) | 2006-01-20 | 2007-01-18 | PHARMACEUTICAL TAX FORMULATION, TAXAN SOLID-MATERIAL COMPOSITION, METHOD FOR PRODUCING TAXAN SOLID-MATERIAL COMPOSITION, COMPOSITION FOR SOLUBILIZING THE TAXAN SOLID-MATERIAL COMPOSITION, AND ELEMENT SET (KIT) FOR INJECTABLE TAX FORMULATION |
| CA002637893A CA2637893A1 (en) | 2006-01-20 | 2007-01-18 | Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| US12/161,625 US20090215883A1 (en) | 2006-01-20 | 2007-01-18 | Pharmaceutical formulation comprising taxane, a solid composition of taxane, a process for preparing said solid composition of taxane, a solubilizing composition of said solid composition of taxane, and a kit for the injectable formulation of taxane |
| MX2008009358A MX2008009358A (es) | 2006-01-20 | 2007-01-18 | Una formulacion farmaceutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubllizante de dicha composicion solida de taxano, y un conjunto de elementos (kit |
| NZ569783A NZ569783A (en) | 2006-01-20 | 2007-01-18 | Surfactant-free freeze-dried solid taxane composition |
| AU2007206876A AU2007206876B2 (en) | 2006-01-20 | 2007-01-18 | Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| RU2008133761/15A RU2429837C2 (ru) | 2006-01-20 | 2007-01-18 | Фармацевтический состав таксана, твердая композиция таксана, способ получения твердой композиции таксана, композиция для солюбилизации указанной твердой композиции таксана и комплект элементов (набор) для состава таксана для инъекций |
| BRPI0706932-4A BRPI0706932A2 (pt) | 2006-01-20 | 2007-01-19 | composição sólida de taxano liofilizada, procedimento para preparar dita composição sólida, formulação farmaçêutica e conjunto (kit) de dita formulação |
| PE2007000063A PE20071243A1 (es) | 2006-01-20 | 2007-01-19 | Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceutica y un conjunto (kit) para la preparacion de una formulacion inyectable de taxano |
| EP07712570A EP1982699A1 (en) | 2006-01-20 | 2007-01-19 | A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| UY30100A UY30100A1 (es) | 2006-01-20 | 2007-01-19 | Una formulacion farmacéutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubilizante de dicha composicion solida de taxano, y un conjunto de elementos (kit |
| UY30099A UY30099A1 (es) | 2006-01-20 | 2007-01-19 | Una composicion solida de taxano liofilizado, un procedimiento para preparar dicha composicion solida, una formulacion farmacéutica y un conjunto (kit) para la preparacion de una formulacion inyectable de taxano |
| US12/161,609 US20090215882A1 (en) | 2006-01-20 | 2007-01-19 | Lyophilized solid taxane composition, a process for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| CA002638034A CA2638034A1 (en) | 2006-01-20 | 2007-01-19 | A lyophilized solid taxane composition, a process for preparing said solid composition, a pharmaceutical formulation and a kit of said formulation |
| AU2007206877A AU2007206877A1 (en) | 2006-01-20 | 2007-01-19 | A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| NZ569968A NZ569968A (en) | 2006-01-20 | 2007-01-19 | A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| PCT/ES2007/070013 WO2007082979A1 (es) | 2006-01-20 | 2007-01-19 | Una composición sólida de taxano liofilizada, un procedimiento para preparar dicha composición sólida, una formulación farmacéutica y un conjunto (kit) de dicha formulación |
| MX2008009357A MX2008009357A (es) | 2006-01-20 | 2007-01-19 | Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceuctica y un conjunto (kit) de dicha formulacion. |
| ZA200805704A ZA200805704B (en) | 2006-01-20 | 2007-01-19 | A solid lyophilized taxane composition, a method for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| JP2008550786A JP2009523771A (ja) | 2006-01-20 | 2007-01-19 | 凍結乾燥した個体状タキサン類組成物、前記組成物を生成する方法、前記組成物の医薬調剤、前記組成物の調剤用キット。 |
| PE2007000062A PE20070945A1 (es) | 2006-01-20 | 2007-01-19 | Una formulacion farmaceutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubilizante de dicha composicion solida de taxano, y un conjunto de elementos (kit |
| ZA200805989A ZA200805989B (en) | 2006-01-20 | 2008-07-09 | Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| GT200800145A GT200800145A (es) | 2006-01-20 | 2008-07-18 | Una composicion solida de taxano liofilizada, un procedimiento para preparar dicha composicion solida, una formulacion farmaceutica y un conjunto (kit) de dicha formulacion |
| GT200800146A GT200800146A (es) | 2006-01-20 | 2008-07-18 | Una formulacion farmaceutica de taxano, una composicion solida de taxano, un procedimiento para la preparacion de dicha composicion solida de taxano, una composicion solubilizante de dicha composicion solida de taxano, y un conjunto de elementos (kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AR20060100208A AR054215A1 (es) | 2006-01-20 | 2006-01-20 | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054215A1 true AR054215A1 (es) | 2007-06-13 |
Family
ID=38134453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20060100208A AR054215A1 (es) | 2006-01-20 | 2006-01-20 | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20090215883A1 (es) |
| EP (2) | EP1994925A4 (es) |
| JP (2) | JP2009523770A (es) |
| AR (1) | AR054215A1 (es) |
| AU (1) | AU2007206877A1 (es) |
| BR (2) | BRPI0706931A2 (es) |
| CA (2) | CA2637893A1 (es) |
| GT (2) | GT200800146A (es) |
| MX (2) | MX2008009358A (es) |
| NZ (2) | NZ569783A (es) |
| PE (2) | PE20071243A1 (es) |
| RU (1) | RU2429837C2 (es) |
| UY (2) | UY30099A1 (es) |
| WO (2) | WO2007082978A1 (es) |
| ZA (2) | ZA200805704B (es) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8110209B2 (en) * | 2002-12-20 | 2012-02-07 | Xeris Pharmaceuticals Inc. | Intracutaneous injection |
| CN1747747B (zh) | 2003-01-06 | 2012-09-05 | 安吉奥开米公司 | 作为穿过血脑屏障的载体的抑酶肽及类似物 |
| MX2007010113A (es) | 2005-02-18 | 2007-12-07 | Angiochem Inc | Polipeptidos de aprotinina para transportar un compuesto a traves de la barrera hematoencefalica. |
| WO2007009229A1 (en) | 2005-07-15 | 2007-01-25 | Angiochem Inc. | Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
| US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US8414525B2 (en) * | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
| US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
| US8414909B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
| CN102014918A (zh) * | 2007-04-20 | 2011-04-13 | 太阳医药工业有限公司 | 由微量沉淀产生的药学组合物 |
| US9365634B2 (en) * | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| MX2009013663A (es) * | 2007-06-22 | 2010-01-27 | Scidose Llc | Formulacion solubilizada de docetaxel sin tween 80. |
| US20090088393A1 (en) * | 2007-09-28 | 2009-04-02 | Zomanex, Llc | Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| AR063111A1 (es) * | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
| KR101478779B1 (ko) | 2007-11-22 | 2015-01-05 | 에스케이케미칼주식회사 | 재수화시간이 향상된 택산 유도체 함유 동결건조 조성물 및이의 제조방법 |
| TR201905480T4 (tr) * | 2008-04-18 | 2019-05-21 | Angiochem Inc | Paklitaksel, paklitaksel analogları veya paklitaksel konjugatlarının farmasötik bileşimleri ve ilgili preparasyon ve kullanım yöntemleri. |
| WO2010024898A2 (en) | 2008-08-29 | 2010-03-04 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
| BRPI0920209A2 (pt) | 2008-10-15 | 2015-12-22 | Angiochem Inc | conjugados de agonistas de glp-1 e usos dos mesmos |
| CN102245636A (zh) | 2008-10-15 | 2011-11-16 | 安吉奥开米公司 | 用于药物递送的依托泊苷和多柔比星结合物 |
| WO2010063122A1 (en) | 2008-12-05 | 2010-06-10 | Angiochem Inc. | Conjugates of neurotensin or neurotensin analogs and uses thereof |
| CA2747220A1 (en) | 2008-12-17 | 2010-06-24 | Richard Beliveau | Membrane type-1 matrix metalloprotein inhibitors and uses thereof |
| US9173891B2 (en) | 2009-04-20 | 2015-11-03 | Angiochem, Inc. | Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog |
| IN2012DN00248A (es) | 2009-07-02 | 2015-05-01 | Angiochem Inc | |
| KR20120053052A (ko) * | 2009-08-25 | 2012-05-24 | 아브락시스 바이오사이언스, 엘엘씨 | 헤지호그 억제제 및 탁산의 나노입자 조성물로의 조합 요법 |
| US20110092579A1 (en) * | 2009-10-19 | 2011-04-21 | Scidose Llc | Solubilized formulation of docetaxel |
| US7772274B1 (en) | 2009-10-19 | 2010-08-10 | Scidose, Llc | Docetaxel formulations with lipoic acid |
| US8912228B2 (en) | 2009-10-19 | 2014-12-16 | Scidose Llc | Docetaxel formulations with lipoic acid |
| US8541465B2 (en) * | 2009-10-19 | 2013-09-24 | Scidose, Llc | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid |
| EP2493466B1 (en) | 2009-10-29 | 2021-03-10 | Sanofi Mature IP | Novel antitumoral use of cabazitaxel |
| WO2011082369A2 (en) * | 2009-12-31 | 2011-07-07 | Mannkind Corporation | Injectable formulations for parenteral administration |
| TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前－乳劑調配物及其製造與使用之方法 |
| WO2011139899A2 (en) | 2010-05-03 | 2011-11-10 | Teikoku Pharma Usa, Inc. | Non-aqueous taxane pro-emulsion formulations and methods of making and using the same |
| AR077384A1 (es) * | 2010-07-05 | 2011-08-24 | Eriochem Sa | Una formulacion farmaceutica inyectable de melfalano. |
| US20120046225A1 (en) | 2010-07-19 | 2012-02-23 | The Regents Of The University Of Colorado, A Body Corporate | Stable glucagon formulations for the treatment of hypoglycemia |
| MX342675B (es) | 2011-03-10 | 2016-10-07 | Xeris Pharmaceuticals Inc | Formulaciones estables para inyeccion parenteral de farmacos de peptido. |
| WO2013067022A1 (en) | 2011-10-31 | 2013-05-10 | Xeris Pharmaceuticals, Inc. | Formulations for the treatment of diabetes |
| US9125805B2 (en) | 2012-06-27 | 2015-09-08 | Xeris Pharmaceuticals, Inc. | Stable formulations for parenteral injection of small molecule drugs |
| JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
| US9018162B2 (en) | 2013-02-06 | 2015-04-28 | Xeris Pharmaceuticals, Inc. | Methods for rapidly treating severe hypoglycemia |
| EP2958554B1 (en) * | 2013-02-19 | 2018-06-06 | Synthon BV | Stable compositions of bendamustine |
| CA2957399C (en) | 2014-08-06 | 2023-09-26 | Xeris Pharmaceuticals, Inc. | Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes |
| EP2985038A1 (en) * | 2014-08-12 | 2016-02-17 | Azad Pharma AG | Lyophilized API preparation |
| WO2016090240A1 (en) * | 2014-12-04 | 2016-06-09 | Astex Pharmaceuticals, Inc. | Pharmaceutical compositions for increasing the bioavailability of poorly soluble drugs |
| US9763892B2 (en) | 2015-06-01 | 2017-09-19 | Autotelic Llc | Immediate release phospholipid-coated therapeutic agent nanoparticles and related methods |
| US9814685B2 (en) * | 2015-06-04 | 2017-11-14 | Crititech, Inc. | Taxane particles and their use |
| US9649364B2 (en) | 2015-09-25 | 2017-05-16 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic formulations in aprotic polar solvents |
| ES2826827T3 (es) | 2015-06-15 | 2021-05-19 | Angiochem Inc | Métodos para el tratamiento de carcinomatosis leptomeníngea |
| US11590205B2 (en) | 2015-09-25 | 2023-02-28 | Xeris Pharmaceuticals, Inc. | Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents |
| TWI752750B (zh) | 2015-09-30 | 2022-01-11 | 香港商慧源香港創新有限公司 | 口服紫杉烷組合物及方法 |
| SG10201913409VA (en) | 2016-04-04 | 2020-03-30 | Crititech Inc | Methods for solid tumor treatment |
| RU2708329C2 (ru) * | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| EP4378463A3 (en) | 2017-06-02 | 2024-10-23 | Xeris Pharmaceuticals, Inc. | Precipitation resistant small molecule drug formulations |
| BR112019023948A2 (pt) | 2017-06-09 | 2020-06-09 | Crititech Inc | tratamento de cistos epiteliais por injeção intracística de partículas antineoplásicas |
| AU2018284247B2 (en) | 2017-06-14 | 2020-04-30 | Crititech Inc. | Methods for treating lung disorders |
| WO2019047812A1 (zh) * | 2017-09-07 | 2019-03-14 | 深圳信立泰药业股份有限公司 | 多西他赛共缀物的药物组合物及制备方法 |
| CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| CN107496352A (zh) * | 2017-10-13 | 2017-12-22 | 深圳万乐药业有限公司 | 一种多烯紫杉醇药物组合物及其制备方法 |
| US12414914B2 (en) * | 2018-07-25 | 2025-09-16 | Bika Biotechnology (Guangzhou) Co., Ltd | Docetaxel composition for injection and preparation method therefor |
| CA3124316C (en) | 2018-12-21 | 2023-07-04 | Modra Pharmaceuticals B.V. | Cancer treatment using docetaxel by controlling peak plasma levels |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| US5698582A (en) | 1991-07-08 | 1997-12-16 | Rhone-Poulenc Rorer S.A. | Compositions containing taxane derivatives |
| US5714512A (en) * | 1991-07-08 | 1998-02-03 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
| US5750561A (en) | 1991-07-08 | 1998-05-12 | Rhone-Poulenc Rorer, S.A. | Compositions containing taxane derivatives |
| FR2698543B1 (fr) | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| KR0180334B1 (ko) | 1995-09-21 | 1999-03-20 | 김윤 | 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법 |
| US6964946B1 (en) * | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| US6441025B2 (en) | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
| US20020039594A1 (en) | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
| HUP9701945A3 (en) | 1997-11-10 | 2000-04-28 | Hexal Ag | Pharmaceutical composition for injection containing cyclodextrin and taxoids |
| US5922754A (en) | 1998-10-02 | 1999-07-13 | Abbott Laboratories | Pharmaceutical compositions containing paclitaxel |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6610317B2 (en) * | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
| KR100883477B1 (ko) * | 1999-05-27 | 2009-02-16 | 아쿠스피어 인코포레이티드. | 다공성 약물 매트릭스의 약제 조성물 |
| WO2000075281A2 (en) | 1999-06-09 | 2000-12-14 | University Technology Corporation | Supercritical fluid-assisted nebulization and bubble drying |
| US20010047162A1 (en) * | 2000-02-17 | 2001-11-29 | Yasumi Yugari | Injection kit and injection device |
| KR20010100194A (ko) | 2000-03-13 | 2001-11-14 | 박호군 | 여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법 |
| KR100412227B1 (ko) * | 2000-05-12 | 2003-12-24 | 주식회사 삼양사 | 상분리에 의한 고분자 미셀의 제조방법 |
| CN1116875C (zh) | 2000-10-19 | 2003-08-06 | 南京振中生物工程有限公司 | 紫杉醇脂质组合物及其制备方法 |
| PL203300B1 (pl) * | 2000-10-31 | 2009-09-30 | Akad Medyczna | Stabilna postać farmaceutyczna leku przeciwnowotworowego oraz sposób wytwarzania stabilnej postaci farmaceutycznej leku przeciwnowotworowego |
| AU2002239282A1 (en) | 2000-11-28 | 2002-06-11 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| US7037528B2 (en) | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
| US20040256749A1 (en) | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
| US20030099674A1 (en) * | 2001-08-11 | 2003-05-29 | Chen Andrew X. | Lyophilized injectable formulations containing paclitaxel or other taxoid drugs |
| US6780324B2 (en) * | 2002-03-18 | 2004-08-24 | Labopharm, Inc. | Preparation of sterile stabilized nanodispersions |
| ITMI20020680A1 (it) | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento |
| ITMI20020681A1 (it) * | 2002-03-29 | 2003-09-29 | Acs Dobfar Spa | Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina |
| KR100573289B1 (ko) | 2002-07-20 | 2006-04-24 | 대화제약 주식회사 | 방광내 투여를 통한 방광암치료용 파클리탁셀 조성물 및그의 제조 방법 |
| KR100508518B1 (ko) | 2002-11-13 | 2005-08-17 | 한미약품 주식회사 | 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체 |
| US6759539B1 (en) * | 2003-02-27 | 2004-07-06 | Chaichem Pharmaceuticals International | Process for isolation and purification of paclitaxel from natural sources |
| US20040247624A1 (en) | 2003-06-05 | 2004-12-09 | Unger Evan Charles | Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| US20050152979A1 (en) | 2003-09-05 | 2005-07-14 | Cell Therapeutics, Inc. | Hydrophobic drug compositions containing reconstitution enhancer |
| KR20050099311A (ko) * | 2004-04-09 | 2005-10-13 | 에이엔에이치 케어연구소(주) | 주사제용 항암제 조성물 |
| US7345093B2 (en) * | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| BRPI0600194A (pt) * | 2006-01-30 | 2007-10-23 | Quiral Quimica Do Brasil S A | composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas |
| CN1850056A (zh) * | 2006-03-06 | 2006-10-25 | 杨典忠 | 多西他赛冻干粉针及其制备方法 |
| AR063111A1 (es) * | 2007-10-03 | 2008-12-30 | Eriochem Sa | Una formulacion farmaceutica de taxano |
-
2006
- 2006-01-20 AR AR20060100208A patent/AR054215A1/es unknown
-
2007
- 2007-01-18 MX MX2008009358A patent/MX2008009358A/es unknown
- 2007-01-18 WO PCT/ES2007/070012 patent/WO2007082978A1/es not_active Ceased
- 2007-01-18 NZ NZ569783A patent/NZ569783A/en not_active IP Right Cessation
- 2007-01-18 BR BRPI0706931-6A patent/BRPI0706931A2/pt not_active IP Right Cessation
- 2007-01-18 US US12/161,625 patent/US20090215883A1/en not_active Abandoned
- 2007-01-18 CA CA002637893A patent/CA2637893A1/en not_active Abandoned
- 2007-01-18 RU RU2008133761/15A patent/RU2429837C2/ru not_active IP Right Cessation
- 2007-01-18 EP EP07712569A patent/EP1994925A4/en not_active Withdrawn
- 2007-01-18 JP JP2008550785A patent/JP2009523770A/ja active Pending
- 2007-01-19 NZ NZ569968A patent/NZ569968A/en not_active IP Right Cessation
- 2007-01-19 AU AU2007206877A patent/AU2007206877A1/en not_active Abandoned
- 2007-01-19 UY UY30099A patent/UY30099A1/es not_active Application Discontinuation
- 2007-01-19 WO PCT/ES2007/070013 patent/WO2007082979A1/es not_active Ceased
- 2007-01-19 JP JP2008550786A patent/JP2009523771A/ja not_active Abandoned
- 2007-01-19 PE PE2007000063A patent/PE20071243A1/es not_active Application Discontinuation
- 2007-01-19 CA CA002638034A patent/CA2638034A1/en not_active Abandoned
- 2007-01-19 BR BRPI0706932-4A patent/BRPI0706932A2/pt not_active IP Right Cessation
- 2007-01-19 ZA ZA200805704A patent/ZA200805704B/xx unknown
- 2007-01-19 PE PE2007000062A patent/PE20070945A1/es not_active Application Discontinuation
- 2007-01-19 EP EP07712570A patent/EP1982699A1/en not_active Withdrawn
- 2007-01-19 MX MX2008009357A patent/MX2008009357A/es not_active Application Discontinuation
- 2007-01-19 UY UY30100A patent/UY30100A1/es not_active Application Discontinuation
- 2007-01-19 US US12/161,609 patent/US20090215882A1/en not_active Abandoned
-
2008
- 2008-07-09 ZA ZA200805989A patent/ZA200805989B/xx unknown
- 2008-07-18 GT GT200800146A patent/GT200800146A/es unknown
- 2008-07-18 GT GT200800145A patent/GT200800145A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1982699A1 (en) | 2008-10-22 |
| AU2007206877A1 (en) | 2007-07-26 |
| JP2009523770A (ja) | 2009-06-25 |
| GT200800145A (es) | 2009-07-21 |
| AU2007206876A1 (en) | 2007-07-26 |
| BRPI0706931A2 (pt) | 2011-04-19 |
| UY30100A1 (es) | 2008-09-02 |
| WO2007082978A1 (es) | 2007-07-26 |
| PE20070945A1 (es) | 2007-10-07 |
| CA2638034A1 (en) | 2007-07-26 |
| GT200800146A (es) | 2008-12-15 |
| BRPI0706932A2 (pt) | 2011-04-19 |
| WO2007082978B1 (es) | 2007-09-07 |
| EP1994925A1 (en) | 2008-11-26 |
| RU2008133761A (ru) | 2010-02-27 |
| EP1994925A4 (en) | 2013-01-23 |
| JP2009523771A (ja) | 2009-06-25 |
| MX2008009358A (es) | 2008-09-10 |
| NZ569968A (en) | 2011-07-29 |
| US20090215883A1 (en) | 2009-08-27 |
| PE20071243A1 (es) | 2008-02-03 |
| CA2637893A1 (en) | 2007-07-26 |
| ZA200805704B (en) | 2009-11-25 |
| MX2008009357A (es) | 2008-09-10 |
| RU2429837C2 (ru) | 2011-09-27 |
| US20090215882A1 (en) | 2009-08-27 |
| UY30099A1 (es) | 2008-09-02 |
| ZA200805989B (en) | 2009-05-27 |
| NZ569783A (en) | 2011-04-29 |
| WO2007082979A1 (es) | 2007-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054215A1 (es) | Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit | |
| Han et al. | Melatonin facilitates adipose‐derived mesenchymal stem cells to repair the murine infarcted heart via the SIRT1 signaling pathway | |
| ECSP099642A (es) | Formulaciones estables de anticuerpo | |
| Monsel et al. | Cell-based therapy for acute organ injury: preclinical evidence and on-going clinical trials using mesenchymal stem cells | |
| EA201170969A1 (ru) | Новые макроциклические ингибиторы репликации вируса гепатита с | |
| ES2572267T3 (es) | Composiciones de insulina de acción súper rápida | |
| MY152013A (en) | Stabilized single-liquid pharmaceutical composition containing docetaxel | |
| RU2008137634A (ru) | Способ уменьшения агрегации белка | |
| CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
| EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
| EA200800726A1 (ru) | Введение ингибиторов дипептидилпептидазы | |
| EA201170527A1 (ru) | Фармацевтические композиции, включающие соединения бороновой кислоты | |
| ECSP088962A (es) | Nuevos herbicidas | |
| JP2018138578A5 (es) | ||
| AR050918A1 (es) | Solucion para infusion de dihidropteridinonas estabilizada para el almacenamiento | |
| NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
| TN2009000481A1 (en) | Novel peptide inhibitors of hepatitis c virus replication | |
| CL2011003192A1 (es) | Acido (2s)-3-(2-fluoro-5-(5-fluoro-1h-pirrolo[2,3-b]piridin-3-il)fenilamino)biciclo[2.2.2]octano-2-carboxilico; metodo para prepararlo; composicion farmaceutica que lo comprende; y su uso en el tratamiento de la influenza; metodo para reducir el virus de la influenza in vitro. | |
| AR063587A1 (es) | Preparcion liquida que comprende pimobendan | |
| EA201200427A1 (ru) | Растворение атеросклеротических бляшек в артериях | |
| AR062659A1 (es) | Composicion de liberacion sostenida de levodopa y metodo para su uso | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
| Li et al. | A DNA-based and bifunctional nanomedicine for alleviating multi-organ injury in sepsis under diabetic conditions | |
| EA200702102A1 (ru) | Пластинки, содержащие стероидные гормоны |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |